Evidence map›Paper›PMID 35773428›Full record

ArticleScientific reports2022

Peptidoglycan compositional analysis of Mycobacterium smegmatis using high-resolution LC-MS.

Binayak Rimal, Sibusiso Senzani, Christopher Ealand, Gyanu Lamichhane, Bavesh Kana, Sung Joon Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Activity Profiling of Mycobacterial L,D-Transpeptidases.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Bacterial glycosylation, it's complicated.Frontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Binayak RimalInstitute of Biomedical Studies, Baylor University, Waco, TX, 76798, USA.
Sibusiso SenzaniNational Health Laboratory Service, Faculty of Health Sciences, DST/NRF Centre of Excellence for Biomedical TB Research, School of Pathology, University of the Witwatersrand, Johannesburg, 2001, South Africa.
Christopher EalandNational Health Laboratory Service, Faculty of Health Sciences, DST/NRF Centre of Excellence for Biomedical TB Research, School of Pathology, University of the Witwatersrand, Johannesburg, 2001, South Africa.
Gyanu LamichhaneDivision of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, 21287, USA.
Bavesh KanaNational Health Laboratory Service, Faculty of Health Sciences, DST/NRF Centre of Excellence for Biomedical TB Research, School of Pathology, University of the Witwatersrand, Johannesburg, 2001, South Africa. bavesh.kana@wits.ac.za.
Sung Joon KimDepartment of Chemistry, Howard University, Chemistry Building, 525 College Street, Washington, DC, 20059, USA. sung.kim@howard.edu.
University of the Witwatersrand · ZAJohns Hopkins University · USHoward University · US

Funding

GLYCOPEPTIDE COMPLEXES WITH BACTERIAL CELL WALLS BY REDORR01GM116130 · NIGMS · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2015 to 2018
$1.2M
A strategy to treat M. abscessus infectionsR21AI137720 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LAMICHHANE, GYANU · 2019 to 2020
$450k
NIAID NIH HHS R21 AI137720NIGMS NIH HHS R01 GM116130NIH HHS AI137720NIH HHS GM116130
6 · The paper itself

Abstract

Peptidoglycan (PG) is the exoskeleton of bacterial cells and is required for their viability, growth, and cell division. Unlike most bacteria, mycobacteria possess an atypical PG characterized by a high degree of unique linkages and chemical modifications which most likely serve as important determinants of virulence and pathogenesis in mycobacterial diseases. Despite this important role, the chemical composition and molecular architecture of mycobacterial PG have yet to be fully determined. Here we determined the chemical composition of PG from Mycobacterium smegmatis using high-resolution liquid chromatography-mass spectrometry. Purified cell walls from the stationary phase were digested with mutanolysin and compositional analysis was performed on 130 muropeptide ions that were identified using an in silico PG library. The relative abundance for each muropeptide ion was measured by integrating the extracted-ion chromatogram. The percentage of crosslink per PG subunit was measured at 45%. While both 3→3 and 4→3 transpeptide cross-linkages were found in PG dimers, a high abundance of 3→3 linkages was found associated with the trimers. Approximately 43% of disaccharides in the PG of M. smegmatis showed modifications by acetylation or deacetylation. A significant number of PG trimers are found with a loss of 41.00 amu that is consistent with N-deacetylation, whereas the dimers show a gain of 42.01 amu corresponding to O-acetylation of the PG disaccharides. This suggests a possible role of PG acetylation in the regulation of cell wall homeostasis in M. smegmatis. Collectively, these data report important novel insights into the ultrastructure of mycobacterial PG.

Indexed as

Mycobacterium smegmatisPeptidoglycanBacterial ProteinsCell WallChromatography, LiquidDisaccharidesTandem Mass SpectrometryBacterial ProteinsDisaccharidesPeptidoglycan

Identifiers

PMID35773428
PMCPMC9247062
OpenAlexW4283729680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.